Pri-Med Podcasts

Your Questions About Migraine Answered

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/your-questions-about-migraine
Overview:
In this podcast, Dr. Dawn Buse will address questions about migraine diagnosis and treatment posed by Pri-Med learners during recent programs. Topics will include deciding when imaging is appropriate in the evaluation of headache, distinguishing between migraine and cluster headache, determining which patients would benefit from preventive migraine therapy, considering how long to use a preventive therapy before determining it to be ineffective, managing menstrual migraines, and treating migraine in children and adolescents.

A Primer on Monkeypox - Frankly Speaking Ep 282

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-282
Overview: Monkeypox is endemic in certain parts of Africa, but outbreaks in Europe and North America have recently occurred. While still uncommon, clinicians need to be alert to the possibility of this diagnosis. This podcast gives you the tools you need to identify risk factors and distinguish the disease from other infections.
Episode resource links:
World Health Organization Health Topics/Monkeypox https://www.who.int/health-topics/monkeypox#tab=tab_1
 
Disease outbreak New/Item/Multi-country monkeypox outbreak: situation update 6-10-2022 https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON392
Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato

Access to Care: Safety of Medication Abortion - Frankly Speaking Ep 281

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-281
Overview: Clinicians may hesitate to provide medication abortion without first performing a pelvic ultrasound or pelvic examination, but recent data may give clinicians more confidence in their decision to do so. This episode explores the evidence for the safety of telehealth-based, or no-test screening, approaches to providing medication abortion for pregnant women at less than 10 weeks’ gestation. 
Episode resource links:
Upadhyay UD, Raymond EG, Koenig LR, et al. Outcomes and Safety of History-Based Screening for Medication Abortion: A Retrospective Multicenter Cohort Study. JAMA Intern Med. Published online March 21, 2022. doi:10.1001/jamainternmed.2022.0217
Upadhyay UD, Koenig LR, Meckstroth KR. Safety and Efficacy of Telehealth Medication Abortions in the US During the COVID-19 Pandemic. JAMA Network Open. 2021;4(8):e2122320. doi:10.1001/jamanetworkopen.2021.22320
Endler M, Lavelanet A, Cleeve A, Ganatra B, Gomperts R, Gemzell-Danielsson K. Telemedicine for medical abortion: a systematic review. BJOG: An International Journal of Obstetrics & Gynaecology. 2019;126(9):1094-1102. doi:10.1111/1471-0528.15684
Guest: Jillian Joseph, MSPAS, PA-C Music Credit: Richard Onorato

Emerging Solutions for Cancer Screening Challenges: Multi-Cancer Early Detection

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/multi-cancer-early-detection
Overview:
Carve out 15 minutes in your day to listen to an expert-led podcast on the current landscape of cancer screening and how emerging technology in multi-cancer early detection (MCED) screening tests will likely improve this landscape. Listen while experts define this new technology, explain how it works, and discuss its benefits and limitations. Find out how available and emerging MCED tests can augment your current screening strategies and optimize cancer detection, potentially catching a greater number of early-stage cancers and saving lives.

Statins for Cardiovascular Disease—It’s All Relative - Frankly Speaking Ep 280

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-280
Overview: Statins are widely used for lowering cholesterol in patients at risk for cardiovascular disease. While the benefit is more established with secondary prevention compared with primary prevention, most of the benefits are reported in relative risk reduction, which can exaggerate the benefit to an individual person. In this podcast, you’ll hear a discussion of a recent systematic review that looked at the absolute risk reduction and relative risk reduction with statins for preventing death, myocardial infarctions, and stroke.
Episode resource links:
Byrne, P. , Demasi, M. , Jones, M. , et al. Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment. JAMA Internal Medicine
Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato

Step It Up! But by How Much? - Frankly Speaking Ep 279

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-279
Overview: Clinicians (and patients) know that walking is beneficial for overall health, but what are the specifics? How many steps per day lower health risks? What impact does walking have on mortality? What’s the best way to count steps? Join us to hear answers to these questions and more as we discuss evidence-based recommendations for steps/day.
Episode resource links:
Paluch, A. E., Bajpai, S., Bassett, D. R., Carnethon, M. R., Ekelund, U., Evenson, K. R., Galuska, D. A., Jefferis, B. J., Kraus, W. E., Lee, I. M., Matthews, C. E., Omura, J. D., Patel, A. V., Pieper, C. F., Rees-Punia, E., Dallmeier, D., Klenk, J., Whincup, P. H., Dooley, E. E., Pettee Gabriel, K., … Steps for Health Collaborative (2022). Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts. The Lancet. Public health, 7(3), e219–e228. https://doi.org/10.1016/S2468-2667(21)00302-9  
 
https://www.cdc.gov/physicalactivity/index.html This website includes data, resources and information for patients and providers for physical activity.
Guest: Jill M. Terrien PhD, ANP-BC  Music Credit: Richard Onorato

Forget About Weed - Frankly Speaking Ep 278

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-278
Overview: Misconceptions abound on the long-term effects of chronic use of marijuana. This episode tackles these misconceptions head-on, highlighting new data on marijuana’s adverse effects on central nervous system function, including loss of memory, IQ points, and executive functioning. It’s a must-listen for clinicians caring for patients engaging in regular marijuana use.
Episode resource links:
Am J Psych 8 Mar 2022 https://doi.org/10.1176/appi.ajp.2021.21060664
Guest: Jillian Joseph, MSPAS, PA-C Music Credit: Richard Onorato

New and Emerging Therapies for Alzheimer Disease: Anti-Amyloid Therapies

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/alzheimer-disease-detection-pt2
Overview:
This short podcast will focus on new and emerging monoclonal antibody therapies targeting β-amyloid, with a focus on the importance of early recognition and diagnosis of Alzheimer disease to allow prompt treatment for patients in the early stages of the disease who may derive the most benefit from these agents.

Why Is Early Detection of Alzheimer Disease So Important?

Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/alzheimer-disease-detection-pt1
Overview:
Despite the growing prevalence and devastating effects of Alzheimer disease (AD), mild cognitive impairment (MCI) often goes unrecognized in the primary care setting. This brief podcast highlights the need for primary care providers to identify individuals with MCI as early as possible so they can be assessed and, if diagnosed with AD, treated promptly. Expert faculty will explore the manifold benefits of early evaluation, which can include identifying reversible causes of MCI, taking advantage of new effective treatments, and reducing patients’ risk of premature mortality. You’ll walk away from this podcast with strategies to help you earlier identify these patients and, ultimately, maintain their cognitive abilities and quality of life for a longer period.

Pneumococcal Vaccines Simplified! - Frankly Speaking Ep 277

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-277
Overview: Join us to discuss a summary of the newly published guidelines for pneumococcal vaccines and to review the most recently approved vaccines. We’ll begin by describing the challenges from the previous guidelines and how these new guidelines address these challenges. Given the burden of pneumococcal disease and that vaccination is our best weapon to combat the disease, you won’t want to miss this episode. 
Episode resource links:
Morga, A., Kimura, T., Feng, Q., Rozario, N., & Schwartz, J. (2022). Compliance to Advisory Committee on Immunization Practices recommendations for pneumococcal vaccination. Vaccine.
 
https://www.medscape.com/viewarticle/967675#vp_1
 
Schulz, P. S., Moore, S. E., Smith, D., Javed, J., & Wilde, A. M. (2022, April). Missed Pneumococcal Vaccination Opportunities in Adults With Invasive Pneumococcal Disease in a Community Health System. In Open Forum Infectious Diseases (Vol. 9, No. 4, p. ofac075). US: Oxford University Press.
 
Center for disease Control and Prevention Resources: App for iphone and android PneumoRecs
Guest: Mariyan L. Montaque, DNP, FNP-BC Music Credit: Richard Onorato